Skip to content

Lineage Cell Therapeutics, Inc.: 10-K filed 2013-03-18

What Lineage Cell Therapeutics, Inc. reported in its annual report filed 2013-03-18 (fiscal FY 2012): 41 published measures, 130 facts as tagged in accession 0001140361-13-012991.

This filing

Form
10-K (annual report)
Filed
2013-03-18
Fiscal period
fiscal FY 2012
Accession
0001140361-13-012991 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Lineage Cell Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3129,748,593USD
At 2011-12-3145,829,695USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-319,584,536USD
At 2011-12-3128,646,001USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-314,349,967USD
At 2011-12-3122,211,897USD
At 2010-12-3133,324,924USD
At 2009-12-3112,189,081USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-6,037,125USD92
2012-01-01 to 2012-12-31-21,425,703USD366
2012-07-01 to 2012-09-30-4,958,014USD92
2012-04-01 to 2012-06-30-5,457,222USD91
2012-01-01 to 2012-03-31-4,973,342USD91
2011-10-01 to 2011-12-31-5,137,814USD92
2011-01-01 to 2011-12-31-16,515,500USD365
2011-07-01 to 2011-09-30-3,737,626USD92
2011-04-01 to 2011-06-30-4,277,928USD91
2011-01-01 to 2011-03-31-3,362,132USD90
2010-01-01 to 2010-12-31-11,184,618USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-19,679,518USD366
2011-01-01 to 2011-12-31-13,593,916USD365
2010-01-01 to 2010-12-31-7,732,884USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-31400,810USD366
2011-01-01 to 2011-12-31960,281USD365
2010-01-01 to 2010-12-31220,771USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,915,327USD366
2011-01-01 to 2011-12-314,434,159USD365
2010-01-01 to 2010-12-313,708,018USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,913,378USD366
2011-01-01 to 2011-12-313,862,414USD365
2010-01-01 to 2010-12-3125,767,456USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-104,687USD366
2011-01-01 to 2011-12-31-1,202,713USD365
2010-01-01 to 2010-12-313,197,419USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-101,895,712USD
At 2011-12-31-80,470,009USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-311,348,554USD
At 2011-12-311,347,779USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,282,507USD366
2011-01-01 to 2011-12-311,217,522USD365
2010-01-01 to 2010-12-31638,709USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-7,059,248USD92
2012-01-01 to 2012-12-31-25,000,677USD366
2012-07-01 to 2012-09-30-5,946,558USD92
2012-04-01 to 2012-06-30-6,079,331USD91
2012-01-01 to 2012-03-31-5,915,540USD91
2011-10-01 to 2011-12-31-5,447,185USD92
2011-01-01 to 2011-12-31-18,686,431USD365
2011-07-01 to 2011-09-30-4,232,365USD92
2011-04-01 to 2011-06-30-4,980,994USD91
2011-01-01 to 2011-03-31-4,027,887USD90
2010-01-01 to 2010-12-31-9,852,133USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-317,179,479USD
At 2011-12-3124,955,374USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-314,390,832USD
At 2011-12-313,146,655USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-311,168,077USD
At 2011-12-311,118,112USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-12-3120,486,792USD
At 2011-12-3118,619,516USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-31404,000USD
At 2011-12-31353,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-10-01 to 2012-12-318,124,795USD92
2012-01-01 to 2012-12-3128,481,733USD366
2012-07-01 to 2012-09-306,780,375USD92
2012-04-01 to 2012-06-307,029,077USD91
2012-01-01 to 2012-03-316,547,486USD91
2011-10-01 to 2011-12-317,078,711USD92
2011-01-01 to 2011-12-3123,041,193USD365
2011-07-01 to 2011-09-305,375,419USD92
2011-04-01 to 2011-06-305,736,547USD91
2011-01-01 to 2011-03-314,850,516USD90
2010-01-01 to 2010-12-3113,532,433USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-12-3155,316USD
At 2011-12-3151,174USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,481,056USD366
2011-01-01 to 2011-12-314,354,762USD365
2010-01-01 to 2010-12-313,680,300USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-31434,271USD366
2011-01-01 to 2011-12-3179,397USD365
2010-01-01 to 2010-12-3127,718USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-3118,116,688USD366
2011-01-01 to 2011-12-3113,699,691USD365
2010-01-01 to 2010-12-318,191,314USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3149,383,209shares
At 2011-12-3149,035,788shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-3193,972USD
At 2011-12-3193,972USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-31-59,570USD
At 2011-12-31-122,749USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-12-3124,294,373USD
At 2011-12-3141,458,181USD
At 2010-12-3149,425,657USD
At 2009-12-3111,046,989USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-312,098,812USD
At 2011-12-311,900,090USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-31750,258USD
At 2011-12-31552,311USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2012-12-3120,486,792USD
At 2011-12-3118,619,516USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31237,496USD
At 2011-12-31258,620USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-312,774,196USD
At 2011-12-312,692,303USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-310USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-25,305,860USD366
2011-01-01 to 2011-12-31-18,443,883USD365
2010-01-01 to 2010-12-31-12,187,207USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-3110,365,045USD366
2011-01-01 to 2011-12-319,341,502USD365
2010-01-01 to 2010-12-315,341,119USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-31386,457USD366
2011-01-01 to 2011-12-31373,349USD365
2010-01-01 to 2010-12-31138,659USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,446,975USD366
2011-01-01 to 2011-12-311,991,200USD365
2010-01-01 to 2010-12-31790,117USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-305,183USD366
2011-01-01 to 2011-12-31242,548USD365
2010-01-01 to 2010-12-31-2,335,074USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-311,131,279USD366
2011-01-01 to 2011-12-310USD365
2010-01-01 to 2010-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-36,322USD366
2011-01-01 to 2011-12-31120,678USD365
2010-01-01 to 2010-12-3177,907USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,141USD366
2011-01-01 to 2011-12-31-31,094USD365
2010-01-01 to 2010-12-3111,094USD365

Inspect the source

Entity
Lineage Cell Therapeutics, Inc. / CIK 0000876343
Captured
2026-09-20T05:01:04.503Z
SEC response SHA-256
de850ac42665e48058d541d948514740e0c9007b61646401dcae831c504c80bf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000876343.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))